BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19951230)

  • 1. From quid pro quo to quid pro bono: reshaping the influence of industry on health care epidemiologists.
    Kirkland KB
    Clin Infect Dis; 2010 Jan; 50(1):93-7. PubMed ID: 19951230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between optometrists and industry representatives.
    Optometry; 2009 Mar; 80(3):149-53. PubMed ID: 19271358
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between optometrists and health care device industry representatives.
    Optometry; 2009 May; 80(5):255-61. PubMed ID: 19418650
    [No Abstract]   [Full Text] [Related]  

  • 4. Conflicts of interest with the health industry.
    Dubois MY
    Pain Med; 2006; 7(5):463-5. PubMed ID: 17014609
    [No Abstract]   [Full Text] [Related]  

  • 5. A perspective on commercial relationships between ophthalmology and industry.
    Jampol LM; Packer S; Mills RP; Day SH; Lichter PR;
    Arch Ophthalmol; 2009 Sep; 127(9):1194-202. PubMed ID: 19752430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The medical-industrial complex: an ethical challenge].
    Engelhardt K
    Dtsch Med Wochenschr; 2005 Jul; 130(30):1778-80. PubMed ID: 16049885
    [No Abstract]   [Full Text] [Related]  

  • 7. Health Professionals "Make Their Choice": Pharmaceutical Industry Leaders' Understandings of Conflict of Interest.
    Grundy Q; Tierney L; Mayes C; Lipworth W
    J Bioeth Inq; 2017 Dec; 14(4):541-553. PubMed ID: 28913595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conflict of interest with industry and the challenges for surgical education.
    Schwarze ML
    J Am Coll Surg; 2009 Dec; 209(6):766-8. PubMed ID: 19959047
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing perceived conflicts of interest while ensuring the continued innovation of medical technology.
    Van Haute A
    J Vasc Surg; 2011 Sep; 54(3 Suppl):31S-3S. PubMed ID: 21872113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doctors and drug companies: the beauty and the beast?
    Guömundsson S
    Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychiatrists' relationships with industry: the principal-agent problem.
    Appelbaum PS; Gold A
    Harv Rev Psychiatry; 2010; 18(5):255-65. PubMed ID: 20825263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring opportunities for collaboration between the corporate sector and the dental education community.
    Alexander D; Clarkson J; Buchanan R; Chadwick G; Chesters R; Drisko CL; Douglass CW; Farrell L; Fletcher K; Makoni F; Monaco M; Nordquist B; Park NI; Riggs S; Schou L; Smales FC; Stamm JW; Toh CG; Volpe T; Ward P; Warren P
    Eur J Dent Educ; 2008 Feb; 12 Suppl 1():64-73. PubMed ID: 18289269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conflict of interest or ideological divide: the need for ongoing collaboration between physicians and industry.
    Duvall DG
    Curr Med Res Opin; 2006 Sep; 22(9):1807-12. PubMed ID: 16968584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflict of interest and the Society for Vascular Surgery.
    Elliott BM;
    J Vasc Surg; 2011 Sep; 54(3 Suppl):3S-11S. PubMed ID: 21872107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug firm conflicting interests. Radical change, not tweaking, is needed.
    Noble JH
    BMJ; 2009 Dec; 339():b5656. PubMed ID: 20044405
    [No Abstract]   [Full Text] [Related]  

  • 18. Collaborations between surgeons and industry are productive and beneficial to patients.
    Nakayama D
    J Am Coll Surg; 2010 Jul; 211(1):146-7; author reply 147. PubMed ID: 20610270
    [No Abstract]   [Full Text] [Related]  

  • 19. Conflict questions. Insurance execs on healthcare boards prompts worry.
    Benko LB
    Mod Healthc; 2005 May; 35(22):10. PubMed ID: 15940804
    [No Abstract]   [Full Text] [Related]  

  • 20. Restrictions on interactions between doctors and industry could ultimately hurt patients.
    Kimmelstiel C
    J Vasc Surg; 2011 Sep; 54(3 Suppl):12S-4S. PubMed ID: 21872108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.